India approves patent-free Covid-19 vaccine

Available for over a year

India has approved the use of a patent-free Covid-19 vaccine, which was developed at Baylor College of Medicine in the US. We speak to Maria Elena Bottazzi, who tell us her team developed Corbevax with the aim of expanding access to essential healthcare for people in poorer countries. Plus, the United Nations says food prices increased by 28% in 2021. Abdolreza Abbassian from the UN’s Food and Agriculture Organization tells us those struggling financially will be hit the hardest by the rise. With the authorities in the United States still attempting to track down everybody involved in the January 6th invasion of the US Capitol, Anjana Susarla of Michigan State University tells us why facial recognition technology is an increasingly important tool in the search. And at CES 2022, we catch up with Remane CEO Ariel Lee, who tells us about her company’s “data-driven haircare solutions”. (Photo: Corbevax has been approved for emergency use in India; Credit: Getty Images)